73 related articles for article (PubMed ID: 2237723)
1. Time to recurrence varies inversely with thickness in clinical stage 1 cutaneous melanoma.
Schultz S; Kane M; Roush R; Miller V; Berd D; Goldman L; Mastrangelo M
Surg Gynecol Obstet; 1990 Nov; 171(5):393-7. PubMed ID: 2237723
[TBL] [Abstract][Full Text] [Related]
2. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
3. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
5. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
6. Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma.
Moehrle M; Kraemer A; Schippert W; Garbe C; Rassner G; Breuninger H
Br J Dermatol; 2004 Aug; 151(2):397-406. PubMed ID: 15327547
[TBL] [Abstract][Full Text] [Related]
7. [Significant prognostic factors for recurrence-free survival after surgical treatment of head-neck melanoma].
Andersson AP; Gottlieb J; Søndergaard K; Hou-Jensen K; Drzewiecki KT
Ugeskr Laeger; 1993 Aug; 155(31):2397-9. PubMed ID: 8346590
[TBL] [Abstract][Full Text] [Related]
8. Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors.
Levy E; Silverman MK; Vossaert KA; Kopf AW; Bart RS; Golomb FM; Levenstein MJ
Melanoma Res; 1991; 1(1):63-7. PubMed ID: 1822771
[TBL] [Abstract][Full Text] [Related]
9. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanomas that defy conventional prognostic indicators.
McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
[TBL] [Abstract][Full Text] [Related]
11. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.
Ringborg U; Andersson R; Eldh J; Glaumann B; Hafström L; Jacobsson S; Jönsson PE; Johansson H; Krysander L; Lagerlöf B
Cancer; 1996 May; 77(9):1809-14. PubMed ID: 8646678
[TBL] [Abstract][Full Text] [Related]
12. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
13. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.
McCarthy WH; Shaw HM; Thompson JF; Milton GW
Surg Gynecol Obstet; 1988 Jun; 166(6):497-502. PubMed ID: 3375961
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
17. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.
Cohn-Cedermark G; Rutqvist LE; Andersson R; Breivald M; Ingvar C; Johansson H; Jönsson PE; Krysander L; Lindholm C; Ringborg U
Cancer; 2000 Oct; 89(7):1495-501. PubMed ID: 11013363
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study.
Gomez-Rivera F; Santillan A; McMurphey AB; Paraskevopoulos G; Roberts DB; Prieto VG; Myers JN
Head Neck; 2008 Oct; 30(10):1284-94. PubMed ID: 18704971
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
[TBL] [Abstract][Full Text] [Related]
20. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]